References

1. Vigani, B.; Rossi, S.; Sandri, G.; Bonferoni, M.C.; Caramella, C.M.; Ferrari, F. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes. Pharmaceutics 2020, 12, 859.
2. Pandey, M.; Choudhury, H.; Abdul-Aziz, A.; Bhattamisra, S.K.; Gorain, B.; Carine, T.; Wee Toong, T.; Yi, N.J.; Win Yi, L. Promising Drug Delivery Approaches to Treat Microbial Infections in the Vagina: A Recent Update. Polymers 2021, 13, 26.
3. Neves, J.D.; de Oliveira, R.P.; de Oliveira, A.P.; Rodrigues, F.; Sarmento, B. Vaginal mucosa and drug delivery. In Mucoadhesive Materials and Drug Delivery Systems, 1st ed.; Wiley: Chichester, UK, 2014; pp. 99–132.
4. Wong, T.W.; Dhanawat, M.; Rathbone, M.J. Vaginal drug delivery: Strategies and concerns in polymeric nanoparticle development. Expert Opin. Drug Deliv. 2014, 11, 1419–1434.
5. Mirza, M.A.; Panda, A.K.; Asif, S.; Verma, D.; Talegaonkar, S.; Manzoor, N.; Khan, A.; Ahmed, F.J.; Dudeja, M.; Iqbal, Z. A vaginal drug delivery model. Drug Deliv. 2016, 23, 3123–3134.
6. Cook, M.T.; Brown, M.B. Polymeric gels for intravaginal drug delivery. J. Control. Release 2018, 270, 145–157.
7. Caramella, C.M.; Rossi, S.; Ferrari, F.; Bonferoni, M.C.; Sandri, G. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv. Drug Deliv. Rev. 2015, 92, 39–52.
8. Matanović, M.R.; Kristl, J.; Grabnar, P.A. Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. Int. J. Pharm. 2014, 472, 262–275.
9. Alexander, A.A.; Khan, J.; Giri, T.K.; Tripathi, D.K.; Saraf, S.; Saraf, S. Advancement in stimuli triggered in situ gelling delivery for local and systemic route. Expert Opin. Drug Deliver. 2012, 9, 1573–1592.
10. Jalalvandi, E.; Shavandi, A. In situ-forming and pH-responsive hydrogel based on chitosan for vaginal delivery of therapeutic agents. J. Mater. Sci. Mater. Med. 2018, 29, 158.
11. Argenta, D.F.; Bernardo, B.D.C.; Chamorro, A.F.; Matos, P.R.; Caon, T. Thermosensitive hydrogels for vaginal delivery of secnidazole as an approach to overcome the systemic side-effects of oral preparations. Eur. J. Pharm. Sci. 2021, 159, 105722.
12. Mennini, N.; Casella, G.; Cirri, M.; Maestrelli, F.; Mura, P. Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone. J. Pharm. Pharmacol. 2016, 68, 762–771.
13. Date, A.A.; Shibata, A.; Goede, M.; Sanford, B.; la Bruzzo, K.; Belshan, M.; Destache, C.J. Development and evaluation of a thermosensitive vaginal gel containing raltegravir+ efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res. 2012, 96, 430–436.
14. Antimisiaris, S.G.; Mourtas, S. Recent advances on anti-HIV vaginal delivery systems development. Adv. Drug Deliv. Rev. 2015, 92, 123–145.
15. Dorr, M.L.; Pierson, R.C.; Daggy, J.; Quinney, S.K.; Haas, D.M. Buccal versus vaginal misoprostol for term induction of labor: A retrospective cohort study. Am. J. Perinatol. 2019, 36, 765.
16. Tosti, C.; Biscione, A.; Morgante, G.; Bifulco, G.; Luisi, S.; Petraglia, F. Hormonal therapy for endometriosis: From molecular research to bedside. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017, 209, 61–66.
17. Osmałek, T.; Froelich, A.; Jadach, B.; Tatarek, A.; Gadziński, P.; Falana, A.; Gralińska, K.; Ekert, M.; Puri, V.; Wrotyńska-Barczyńska, J. Recent Advances in Polymer-Based Vaginal Drug Delivery Systems. Pharmaceutics 2021, 13, 884.
18. Palmeira-de-Oliveira, R.; Palmeira-de-Oliveira, A.; Martinez-de-Oliveira, J. New strategies for local treatment of vaginal infections. Adv. Drug Deliv. Rev. 2015, 92, 105–122.
19. Jeong, B.; Kim, S.W.; Bae, Y.H. Thermosensitive sol–gel reversible hydrogels. Adv. Drug Deliv. Rev. 2012, 64, 154–162.
20. Taurin, S.; Almomen, A.A.; Pollak, T.; Kim, S.J.; Maxwell, J.; Peterson, C.M.; Owen, S.C.; Janát-Amsbury, M.M. Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery. J. Drug Target. 2018, 26, 533–550.
21. Agrawal, M.; Saraf, S.; Saraf, S.; Dubey, S.K.; Puri, A.; Gupta, U.; Kesharwani, P.; Ravichandiran, V.; Kumar, P.; Naidu, V.G.M.; et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J. Control. Release 2020, 327, 235–265.
22. Bazban-Shotorbani, S.; Hasani-Sadrabadi, M.M.; Karkhaneh, A.; Serpooshan, V.; Jacob, K.I.; Moshaverinia, A.; Mahmoudi, M. Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications. J. Control. Release 2017, 253, 46–63.
23. Bahram, M.; Mohseni, N.; Moghtader, M. An introduction to hydrogels and some recent applications. In Emerging Concepts in Analysis and Applications of Hydrogels; IntechOpen: London, UK, 2016.
24. Ruel-Gariepy, E.; Leroux, J.-C. In situ-forming hydrogels—review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 2004, 58, 409–426.
25. da Silva, J.B.; Cook, M.T.; Bruschi, M.L. Thermoresponsive systems composed of poloxamer 407 and HPMC or NaCMC: Mechanical, rheological and sol-gel transition analysis. Carbohydr. Polym. 2020, 240, 116268.
26. Pickar, J.; Amadio, J.; Bernick, B.; Mirkin, S. Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule. Climacteric 2016, 19, 181–187.
27. Abdelaziz, A.; Mahmoud, A.A.; Ellaithy, M.I.; Abees, S.H. Pre-induction cervical ripening using two different dinoprostone vaginal preparations: A randomized clinical trial of tablets and slow release retrievable insert. Taiwan. J. Obstet. Gynecol. 2018, 57, 560–566.
28. Bernkop-Schnürch, A.; Hornof, M. Intravaginal Drug Delivery Systems: Design, Challenges, and Solutions. Am. J. Adv. Drug Deliv. 2003, 1, 241–254.
29. Bolla, D.; Weissleder, S.V.; Radan, A.P.; Gasparri, M.L.; Raio, L.; Müller, M.; Surbek, D. Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: A cohort study. BMC Pregnancy Childbirth 2018, 18, 149.
30. Peet, M.M.; Agrahari, V.; Anderson, S.M.; Hanif, H.; Singh, O.N.; Thurman, A.R.; Doncel, G.F.; Clark, M.R. Topical Inserts: A Versatile Delivery Form for HIV Prevention. Pharmaceutics 2019, 11, 374.
31. Liu, J.H.; Bernick, B.; Mirkin, S. Estradiol softgel inserts for the treatment of VVA symptoms: An expert opinion. Expert Opin. Drug Deliv. 2020, 17, 1573–1581.
32. Machado, R.M.; Palmeira-de-Oliveira, A.; Martinez-de-Oliveira, J.; Palmeira-de-Oliveira, R. Vaginal semisolid products: Technological performance considering physiologic parameters. Eur. J. Pharm. Sci. 2017, 109, 556–568.
33. Küng, E.; Fürnkranz, U.; Walochnik, J. Chemotherapeutic options for the treatment of human trichomoniasis. Int. J. Antimicrob. Agents 2019, 53, 116–127.
34. Friend, D.R. Drug delivery for the treatment of endometriosis and uterine fibroids. Drug Deliv. Transl. Res. 2017, 7, 829–839.
35. Wang, X.; Liu, S.; Guan, Y.; Ding, J.; Ma, C.; Xie, Z. Vaginal drug delivery approaches for localized management of cervical cancer. Adv. Drug Deliv. Rev. 2021, 174, 114–126.
36. Brache, V.; Faundes, A. Contraceptive vaginal rings: A review. Contraception 2010, 82, 418–427.
37. Velázquez, N.S.; Turino, L.N.; Luna, J.A.; Mengatto, L.N. Progesterone loaded thermosensitive hydrogel for vaginal application: Formulation and in vitro comparison with commercial product. Saudi Pharm. J. 2019, 27, 1096–1106.
38. Marcotte, H.; Krogh Andersen, K.; Lin, Y.; Zuo, F.; Zeng, Z.; Larsson, P.G.; Brandsborg, E.; Brønstad, G.; Hammarström, L. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag® probiotic vaginal capsules. Microbiol. Res. 2017, 205, 88–98.
39. Child, T.; Leonard, S.A.; Evans, J.S.; Lass, A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod. Biomed. Online 2018, 36, 630–645.
40. Sarwal, A.; Singh, G.; Singh, S.; Singh, K.; Sinha, V. Novel and effectual delivery of an antifungal agent for the treatment of persistent vulvovaginal candidiasis. J. Pharm. Investig. 2019, 49, 135–147.
41. Enggi, C.K.; Isa, H.T.; Sulistiawati, S.; Ardika, K.A.R.; Wijaya, S.; Asri, R.M.; Mardikasari, S.A.; Donnelly, R.F.; Permana, A.D. Development of thermosensitive and mucoadhesive gels of cabotegravir for enhanced permeation and retention profiles in vaginal tissue: A proof of concept study. Int. J. Pharm. 2021, 609, 121182.
42. Vigani, B.; Faccendini, A.; Rossi, S.; Sandri, G.; Bonferoni, M.C.; Grisoli, P.; Ferrari, F. Development of a mucoadhesive in situ gelling formulation for the delivery of Lactobacillus gasseri into vaginal cavity. Pharmaceutics 2019, 11, 511.
43. Choi, S.G.; Lee, S.-E.; Kang, B.-S.; Ng, C.L.; Davaa, E.; Park, J.-S. Thermosensitive and mucoadhesive sol-gel composites of paclitaxel/dimethyl-β-cyclodextrin for buccal delivery. PLoS ONE 2014, 9, e109090.
44. Smoleński, M.; Karolewicz, B.; Gołkowska, A.M.; Nartowski, K.P.; Małolepsza-Jarmołowska, K. Emulsion-Based Multicompartment Vaginal Drug Carriers: From Nanoemulsions to Nanoemulgels. Int. J. Mol. Sci. 2021, 22, 6455.
45. Araujo, V.H.S.; de Souza, M.P.C.; Carvalho, G.C.; Duarte, J.L.; Chorilli, M. Chitosan-based systems aimed at local application for vaginal infections. Carbohydr. Polym. 2021, 261, 117919.
46. Zierden, H.C.; Josyula, A.; Shapiro, R.L.; Hsueh, H.T.; Hanes, J.; Ensign, L.M. Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery. Trends Mol. Med. 2021, 27, 436–450.
47. Lalan, M.S.; Patel, V.N.; Misra, A. Polymers in vaginal drug delivery: Recent advancements. In Applications of Polymers in Drug Delivery, 2nd ed.; Elsevier: Amsterdam, The Netherlands, 2021; pp. 281–303.
48. Devadasu, V.R.; Deb, P.K.; Maheshwari, R.; Sharma, P.; Tekade, R.K. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs. In Dosage Form Design Considerations; Academic Press: Cambridge, MA, USA, 2018; pp. 149–178.
49. Lacey, C.; Woodhall, S.; Qi, Z.; Sawant, S.; Cowen, M.; McCormack, S.; Jiang, S. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial. Int. J. STD AIDS 2010, 21, 714–717.
50. Liu, C.; Jiang, X.; Gan, Y.; Yu, M. Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art. Med. Drug Discov. 2021, 12, 100110.
51. Tuğcu-Demiröz, F.; Saar, S.; Kara, A.A.; Yıldız, A.; Tunçel, E.; Acartürk, F. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine. Eur. J. Pharm. Sci. 2021, 161, 105801.
52. Halder, J.; Pradhan, D.; Kar, B.; Ghosh, G.; Rath, G. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. Nanomed. Nanotechnol. Biol. Med. 2021, 40, 102494.
53. Vanić, Ž.; Škalko-Basnet, N. Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver? Eur. J. Pharm. Sci. 2013, 50, 29–41.
54. El-Hammadi, M.M.; Arias, J.L. Nanomedicine for vaginal drug delivery. In Theory and Applications of Nonparenteral Nanomedicines; Elsevier: Amsterdam, The Netherlands, 2021; pp. 235–257.
55. El-Hammadi, M.M.; Arias, J.L. Nanotechnology for vaginal drug delivery and targeting. In Nanoengineered Biomaterials for Advanced Drug Delivery; Elsevier: Amsterdam, The Netherlands, 2020; pp. 647–682.
56. Kim, Y.-T.; Shin, B.-K.; Garripelli, V.K.; Kim, J.-K.; Davaa, E.; Jo, S.; Park, J.-S. A thermosensitive vaginal gel formulation with HPγCD for the pH-dependent release and solubilization of amphotericin B. Eur. J. Pharm. Sci. 2010, 41, 399–406.
57. Chindamo, G.; Sapino, S.; Peira, E.; Chirio, D.; Gallarate, M. Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials. Nanomaterials 2021, 11, 311.
58. Ramyadevi, D.; Rajan, K.S.; Vedhahari, B.N.; Ruckmani, K.; Subramanian, N. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes. Colloids Surf. B 2016, 146, 260–270.
59. Iqbal, R.; Qureshi, O.S.; Yousaf, A.M.; Raza, S.A.; Sarwar, H.S.; Shahnaz, G.; Saleem, U.; Sohail, M.F. Enhanced solubility and biopharmaceutical performance of atorvastatin and metformin via electrospun polyvinylpyrrolidone-hyaluronic acid composite nanoparticles. Eur. J. Pharm. Sci. 2021, 161, 105817.
60. Deshkar, S.S.; Palve, V.K. Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery. J. Drug Deliv. Sci. Technol. 2019, 49, 277–285.
61. Shaaban, O.M.; Fetih, G.N.; Abdellah, N.H.; Ismail, S.; Ibrahim, M.A.; Ibrahim, E.S.A. Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel. J. Obstet. Gynaecol. Res. 2011, 37, 874–881.
62. Jalalvandi, E.; Jafari, H.; Amorim, C.A.; Petri, D.F.S.; Nie, L.; Shavandi, A. Vaginal Administration of Contraceptives. Sci. Pharm. 2021, 89, 3.
63. Major, I.; McConville, C. Vaginal drug delivery for the localised treatment of cervical cancer. Drug Deliv. Transl. Res. 2017, 7, 817–828.
64. Traore, Y.L.; Chen, Y.; Ho, E.A. Current state of microbicide development. Clin. Pharmacol. Ther. 2018, 104, 1074–1081.
65. Shi, S.; Nguyen, P.K.; Cabral, H.J.; Diez-Barroso, R.; Derry, P.J.; Kanahara, S.M.; Kumar, V.A. Development of peptide inhibitors of HIV transmission. Bioact. Mater. 2016, 1, 109–121.
66. Mahalingam, A.; Jay, J.I.; Langheinrich, K.; Shukair, S.; McRaven, M.D.; Rohan, L.C.; Herold, B.C.; Hope, T.J.; Kiser, P.F. Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system. Biomaterials 2011, 32, 8343–8355.
67. Shaikh, R.P.; Pillay, V.; Choonara, Y.E.; du Toit, L.C.; Ndesendo, V.M.; Bawa, P.; Cooppan, S. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech 2010, 11, 441–459.
68. Navath, R.S.; Menjoge, A.R.; Dai, H.; Romero, R.; Kannan, S.; Kannan, R.M. Injectable PAMAM dendrimer–PEG hydrogels for the treatment of genital infections: Formulation and in vitro and in vivo evaluation. Mol. Pharm. 2011, 8, 1209–1223.
69. Nie, L.; Zou, P.; Dong, J.; Sun, M.; Ding, P.; Han, Y.; Ji, C.; Zhou, Q.; Yuan, H.; Suo, J. Injectable vaginal hydrogels as a multi-drug carrier for contraception. Appl. Sci. 2019, 9, 1638.
70. Bahamondes, L.; Bahamondes, M.V. New and emerging contraceptives: A state-of-the-art review. Int. J. Womens Health 2014, 6, 221.
71. Liu, Y.; Yang, F.; Feng, L.; Yang, L.; Chen, L.; Wei, G.; Lu, W. In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models. Acta Pharm. Sin. B 2017, 7, 502–509.
72. das Neves, J.; Nunes, R.; Rodrigues, F.; Sarmento, B. Nanomedicine in the development of anti-HIV microbicides. Adv. Drug Deliv. Rev. 2016, 103, 57–75.
73. Lakshmi, Y.S.; Kumar, P.; Kishore, G.; Bhaskar, C.; Kondapi, A.K. Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles. Sci. Rep. 2016, 6, 25479.
74. Mesquita, L.; Galante, J.; Nunes, R.; Sarmento, B.; das Neves, J. Pharmaceutical vehicles for vaginal and rectal administration of anti-HIV microbicide nanosystems. Pharmaceutics 2019, 11, 145.
75. Li, Z.; Cho, S.; Kwon, I.C.; Janát-Amsbury, M.M.; Huh, K.M. Preparation and characterization of glycol chitin as a new thermogelling polymer for biomedical applications. Carbohydr. Polym. 2013, 92, 2267–2275.
76. Almomen, A.; Cho, S.; Yang, C.-H.; Li, Z.; Jarboe, E.A.; Peterson, C.M.; Huh, K.M.; Janát-Amsbury, M.M. Thermosensitive progesterone hydrogel: A safe and effective new formulation for vaginal application. Pharm. Res. 2015, 32, 2266–2279.
77. Arun Karthick, R.; Ramya Devi, D.; Vedha Hari, B.N. Investigation of sustained release mucoadhesive in-situ gel system of Secnidazole for the persistent treatment of vaginal infections. J. Drug Deliv. Sci. Technol. 2018, 43, 362–368.
78. Patel, P.; Patel, P. Formulation and evaluation of clindamycin HCL in situ gel for vaginal application. Int. J. Pharm. Investig. 2015, 5, 50.
79. Vandenhaute, M.; Schelfhout, J.; Van Vlierberghe, S.; Mendes, E.; Dubruel, P. Cross-linkable, thermo-responsive Pluronic® building blocks for biomedical applications: Synthesis and physico-chemical evaluation. Eur. Polym. J. 2014, 53, 126–138.
80. Lu, C.; Liu, M.; Fu, H.; Zhang, W.; Peng, G.; Zhang, Y.; Cao, H.; Luo, L. Novel thermosensitive in situ gel based on poloxamer for uterus delivery. Eur. J. Pharm. Sci. 2015, 77, 24–28.
81. Soliman, G.M.; Fetih, G.; Abbas, A.M. Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: In vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation. Drug Dev. Ind. Pharm. 2017, 43, 399–408.
82. Abd Ellah, N.H.; Abouelmagd, S.A.; Abbas, A.M.; Shaaban, O.M.; Hassanein, K.M.A. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion. Int. J. Pharm. 2018, 538, 279–286.
83. Yang, T.-T.; Cheng, Y.-Z.; Qin, M.; Wang, Y.-H.; Yu, H.-L.; Wang, A.-L.; Zhang, W.-F. Thermosensitive chitosan hydrogels containing polymeric microspheres for vaginal drug delivery. Biomed. Res. Int. 2017, 2017, 3564060.
84. Hu, X.; Tang, Y.; Wang, Q.; Li, Y.; Yang, J.; Du, Y.; Kennedy, J.F. Rheological behaviour of chitin in NaOH/urea aqueous solution. Carbohydr. Polym. 2011, 83, 1128–1133.
85. Dos Santos, A.M.; Carvalho, S.G.; Araujo, V.H.S.; Carvalho, G.C.; Gremião, M.P.D.; Chorilli, M. Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections. Int. J. Pharm. 2020, 590, 119867.
86. Akash, M.S.H.; Rehman, K. Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives. J. Control. Release 2015, 209, 120–138.
87. Echeverria, C.; Fernandes, S.N.; Godinho, M.H.; Borges, J.P.; Soares, P.I. Functional stimuli-responsive gels: Hydrogels and microgels. Gels 2018, 4, 54.
88. Pandey, P.; Cabot, P.J.; Wallwork, B.; Panizza, B.J.; Parekh, H.S. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels-A platform for therapeutic delivery to mucosal sinus tissue. Eur. J. Pharm. Sci. 2017, 96, 499–507.
89. Russo, E.; Villa, C. Poloxamer hydrogels for biomedical applications. Pharmaceutics 2019, 11, 671.
90. Ci, L.; Huang, Z.; Liu, Y.; Liu, Z.; Wei, G.; Lu, W. Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: Preparation, characterization and application in a vaginal drug delivery system. Acta Pharm. Sin. B 2017, 7, 593–602.
91. Barros, S.C.; da Silva, A.A.; Costa, D.B.; Cesarino, I.; Costa, C.M.; Lanceros-Méndez, S.; Pawlicka, A.; Silva, M.M. Thermo-sensitive chitosan–cellulose derivative hydrogels: Swelling behaviour and morphologic studies. Cellulose 2014, 21, 4531–4544.
92. Klouda, L. Thermoresponsive hydrogels in biomedical applications: A seven-year update. Eur. J. Pharm. Biopharm. 2015, 97, 338–349.
93. Chatterjee, S.; Hui, P.C.-L. Review of Applications and Future Prospects of Stimuli-Responsive Hydrogel Based on Thermo-Responsive Biopolymers in Drug Delivery Systems. Polymers 2021, 13, 2086.
94. Chai, Q.; Jiao, Y.; Yu, X. Hydrogels for biomedical applications: Their characteristics and the mechanisms behind them. Gels 2017, 3, 6.
95. Chen, D.; Yu, H.; Sun, K.; Liu, W.; Wang, H. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery. Drug Deliv. 2014, 21, 258–264.
96. Qin, C.; Zhou, J.; Zhang, Z.; Chen, W.; Hu, Q.; Wang, Y. Convenient one-step approach based on stimuli-responsive sol-gel transition properties to directly build chitosan-alginate core-shell beads. Food Hydrocoll. 2019, 87, 253–259.
97. Cirri, M.; Maestrelli, F.; Scuota, S.; Bazzucchi, V.; Mura, P. Development and microbiological evaluation of chitosan and chitosan-alginate microspheres for vaginal administration of metronidazole. Int. J. Pharm. 2021, 598, 120375.
98. Moreno, M.A.; Gómez-Mascaraque, L.G.; Arias, M.; Zampini, I.C.; Sayago, J.E.; Ramos, L.L.P.; Schmeda-Hirschmann, G.; López-Rubio, A.; Isla, M.I. Electrosprayed chitosan microcapsules as delivery vehicles for vaginal phytoformulations. Carbohydr. Polym. 2018, 201, 425–437.
99. Rodriguez-Tenreiro, C.; Diez-Bueno, L.; Concheiro, A.; Torres-Labandeira, J.J.; Alvarez-Lorenzo, C. Cyclodextrin/carbopol micro-scale interpenetrating networks (ms-IPNs) for drug delivery. J. Control. Release 2007, 123, 56–66.
100. Migliozzi, S.; Angeli, P.; Mazzei, L. Gelation kinetics of non-aqueous Carbopol dispersions. Colloids Surf. B 2019, 577, 84–95.
101. Singh, V.K.; Anis, A.; Banerjee, I.; Pramanik, K.; Bhattacharya, M.K.; Pal, K. Preparation and characterization of novel carbopol based bigels for topical delivery of metronidazole for the treatment of bacterial vaginosis. Mater. Sci. Eng. C 2014, 44, 151–158.
102. Sassi, A.B.; McCullough, K.D.; Cost, M.R.; Hillier, S.L.; Rohan, L.C. Permeability of tritiated water through human cervical and vaginal tissue. J. Pharm. Sci. 2004, 93, 2009–2016.
103. Ching, S.H.; Bansal, N.; Bhandari, B. Alginate gel particles–A review of production techniques and physical properties. Crit. Rev. Food Sci. Nutr. 2017, 57, 1133–1152.
104. Cao, L.; Lu, W.; Mata, A.; Nishinari, K.; Fang, Y. Egg-box model-based gelation of alginate and pectin: A review. Carbohydr. Polym. 2020, 242, 116389.
105. Mishra, R.; Soni, K.; Mehta, T. Mucoadhesive vaginal film of fluconazole using cross-linked chitosan and pectin. J. Therm. Anal. Calorim. 2017, 130, 1683–1695.
106. Bakke, A.J.; Zaveri, T.; Higgins, M.J.; Ziegler, G.R.; Hayes, J.E. Design aspects of vaginal applicators that influence acceptance among target users. Sci. Rep. 2021, 11, 9802.
107. Montesino, M.; Labrie, F.; Archer, D.F.; Zerhouni, J.; Côté, I.; Lavoie, L.; Beauregard, A.; Martel, C.; Vaillancourt, M.; Moyneur, E. Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator. Gynecol. Endocrinol. 2016, 32, 240–245.
108. Das Neves, J.; Notario-Pérez, F.; Sarmento, B. Women-specific routes of administration for drugs: A critical overview. Adv. Drug Deliv. Rev. 2021, 176, 113865.
109. Omar, R.F.; Trottier, S.; Brousseau, G.; Ouellet, C.; Danylo, A.; Ong, T.; Bergeron, M.G. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: A magnetic resonance imaging study. J. Obstet. Gynaecol. Can. 2014, 36, 42–50.
110. Coppola, J.S. A New Vaginal pH Regulator for Hormone-Free, On-Demand Contraception. Nurs. Womens Health 2021, 25, 152–155.
111. Brache, V.; Cohen, J.A.; Cochon, L.; Alvarez, F. Evaluating the clinical safety of three vaginal applicators: A pilot study conducted in the Dominican Republic. Contraception 2006, 73, 72–77.
112. Brunner, H.; Theodor, R.A. Multiple use applicator for vaginal tablets/vaginal inserts: Compliance verification and suitability studies. BMC Womens Health 2020, 20, 235.